XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Investments (Details 4) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Net sales $ 191,782 $ 3,229 $ 404,024 $ 3,229
Gross Profit 178,430 910 389,173 910
Net loss (614,453) (736,040) (1,487,770) (1,449,662)
Share of losses from investments accounted for using the equity method $ (85,923) (85,923)
Rgene Corporation [Member]        
Net sales    
Gross Profit    
Net loss     (49,896) (138,888)
Share of losses from investments accounted for using the equity method    
BioFirst Corporation [Member]        
Net sales     20,446 21,629
Gross Profit     4,214 4,584
Net loss     (543,582) (582,718)
Share of losses from investments accounted for using the equity method     $ (117,424) $ (125,483)